Navigation Links
Optimer Pharmaceuticals and Astellas Announce Collaboration to Commercialize Fidaxomicin for Clostridium difficile infection (CDI) in Europe and Certain Other Countries in Middle East, Africa and CIS
Date:2/7/2011

nts included in this press release that are not a description of historical facts are forward-looking statements, including without limitation all statements related to the potential regulatory approval and commercialization of fidaxomicin, future activities conducted under the collaboration and license agreement, the potential benefits of the collaboration and license agreement, Optimer's potential receipt of up-front, milestone and royalty payments, the incidence of CDI and limitations of current treatment options. Words such as "believes," "anticipates," "plans," "expects," "intend," "will," "goal" and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by Optimer that any of its plans will be achieved. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in Optimer's and Astellas' respective businesses including, without limitation, risks relating to: the implementation and continuation of the collaboration and license agreement, each party's performance of its respective obligations under the collaboration and license agreement, Optimer's and Astellas' ability to commercialize fidaxomicin, the ability to maintain market exclusivity for fidaxomicin in the territory, Astellas' ability to terminate the collaboration and license agreement, the development of alternative treatments for or means of preventing CDI, whether and when regulatory authorities will review or approve Optimer's or Astellas' applications for marketing approval of fidaxomicin, whether healthcare professionals will prescribe fidaxomicin, if approved, whether fidaxomicin will receive reimbursement coverage from healthcare payors and government agencies, the timing and receipt of payments and fees, if any, from Astellas and other risks detailed in Optimer's filings with the Securities and Exchange Commission. ContactsOptimer Ph
'/>"/>
SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
4. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
5. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
6. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
7. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
8. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
9. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
10. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
11. Optimer Pharmaceuticals to Host Investor and Analyst Event on November 18
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... , Nov. 21, 2014 Statistics released ... and drunk driving increase astronomically during the holidays, beginning ... in many cities. The data, ... Monitoring Systems as part of their annual ... paints a picture of high-risk drinking and increased rates ...
(Date:11/22/2014)... HILL, N.C. , Nov. 21, 2014 /PRNewswire/ ... healthcare system. Undoubtedly, the growing influence of patients ... spend for marketing interactions. Now, more than ever, ... retain patients for medical products is essential. ... firm, Best Practices, LLC, benchmarked companies spent about ...
(Date:11/21/2014)...  Tandem Diabetes Care ® , Inc. (NASDAQ: ... and manufacturer of the t:slim ® Insulin ... non-profit dedicated to improving diabetes therapy management by ... diabetes data accessibility. This partnership will enable users ... development, to download and access data from their ...
Breaking Medicine Technology:Alarming Stats Show Holiday Drinking an Issue for Many 2New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3
(Date:11/24/2014)... 24, 2014 "My friend was killed ... to cross the street in his motorized wheelchair," said ... him. I came up with this idea so that ... , He developed the Safety Lites to make a ... conditions. The device ensures that motorists can see the ...
(Date:11/23/2014)... November 24, 2014 For the coming ... retailer, has launched a great promotion for many products, ... Customers can get the best choice with amazing discounts, ... at Tidebuy.com. , It is easy to buy ... Besides that, this selection is also famous for delicate ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 Pro Ace Care, ... that it will now be providing an 8 year warranty ... hot water tank installations went up due to the impending ... assure its customers of the premium service that the company ... 8 year warranty on John Wood and Bradford hot water ...
(Date:11/23/2014)... (HealthDay News) -- The holidays can be a challenge ... can trigger major meltdowns, an expert says. "Holidays ... circumstances, but when you have children with special needs, ... therapy professor at University of the Sciences in Philadelphia, ... to let your hosts or visitors know what special ...
(Date:11/23/2014)... To show thanks to new and old ... white evening dresses for weddings. Customers who need ... iFitDress.com is a distinguished dress manufacturer, and it is among ... customers for a very long time. The CEO of this ... will be able to buy not only a beautiful dress, ...
Breaking Medicine News(10 mins):Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2
... The ... VGI will unveil its new VerteLX™ prototypes at the upcoming Congress of Neurological Surgeons ... ... Innovations, Inc (VGI), announced today that its VerteLoc™ Minimally Invasive Spine Stabilization system has ...
... and Demonstration Project reports unveiled at Washington, DC meeting ... change the shape of health care will be the ... primary care-based model poised to transform health care delivery. ... Summit will feature a keynote address from Rep. Allyson ...
... Nationally-known experts Kenneth J. Doka, PhD, MDiv, and ... of helping grieving people cope with the holidays during ... Monday, November 16 from 1pm-2pm EST. , "Facing loss ... grief during the holidays, traditionally times filled with joy ...
... China, Oct. 20 /PRNewswire-Asia/ -- China Medicine ... "the Company"), a leading,distributor and developer of ... nutritional and dietary-supplements,medical devices, and medical formulations ... today that one of its major products ...
... but experts urge caution , TUESDAY, Oct. 20 (HealthDay News) ... that dangerous blood clots in the lungs, known as pulmonary ... legs or other parts of the lower body, which then ... A study appearing in the October issue of the ...
... ... Training , ... Falls, NJ (PRWEB) - Janet O. Penn, president of Janet Penn Consulting, has announced ... totally web-based interface allows corporations, government agencies and businesses to transfer sensitive, confidential files ...
Cached Medicine News:Health News:VerteLoc™ Surpasses 750 Procedures....VerteLX™ Prototypes To Be Unveiled at Upcoming CNS Meeting in New Orleans 2Health News:Rep. Allyson Schwartz to Keynote National Patient-Centered Primary Care Collaborative Summit 2Health News:Rep. Allyson Schwartz to Keynote National Patient-Centered Primary Care Collaborative Summit 3Health News:Hospice Foundation of America Presents Webinar on 'Grief, Holidays, and Family Dynamics' 2Health News:China Medicine Corporation's Levocarnitine Dried Powder Injection Was Registered with the Ministry of Health of Pakistan 2Health News:China Medicine Corporation's Levocarnitine Dried Powder Injection Was Registered with the Ministry of Health of Pakistan 3Health News:Leg Clots May Not Travel to Lungs 2Health News:Leg Clots May Not Travel to Lungs 3Health News:Document Security Suites Provide Highly Secure Online File Transfer, Improve Profitability 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: